Liver and cardiac iron overload is harmful to HLA-identical hematopoietic stem cell transplantation in thalassemia children: an MRI detection
|
|
- Christina Simon
- 5 years ago
- Views:
Transcription
1 Chinese Journal of Tissue Engineering Research November 28, 2017 Vol.21, No.33 MRI ( ). MRI [J] (33): DOI: /j.issn ORCID: X( ) (1) (2) (3) (1) (2) (1) MRI T2* (2) (1) (2) / U > µg/l :R394.2 :B : (2017) β MRI T2* β 81 >3 MRI β MRI T2* (r=0.229 P=0.043) (r=0.266 P=0.017) (r= P=0.009) (r=0.251 P=0.024) (r=0.276 P=0.013) β β β T2* β (2014A ) (2014B012) Liver and cardiac iron overload is harmful to HLA-identical hematopoietic stem cell transplantation in thalassemia children: an MRI detection Yang Wen-jing 1, 2, Liao Jian-yun 1, Wen Jian-yun 1, Ruan Yong-sheng 1, Chen Li-bai 1, He Yue-lin 1, Li Chun-fu 1, Wu Xue-dong 1 ( 1 Department of Pediatrics, Nanfang Hospital, Southern Medical University, Guangzhou , Guangdong Province, China; 2 Department of Pediatrics, Liuzhou Municipal Liutie Central Hospital, Liuzhou , Guangxi Zhuang Autonomous Region, China) Yang Wen-jing, Master, Attending physician, Department of Pediatrics, Nanfang Hospital, Southern Medical University, Guangzhou , Guangdong Province, China; Department of Pediatrics, Liuzhou Municipal Liutie Central Hospital, Liuzhou , Guangxi Zhuang Autonomous Region, China Corresponding author: Wu Xue-dong, Chief physician, Department of Pediatrics, Nanfang Hospital, Southern Medical University, Guangzhou , Guangdong Province, China ISSN CN /R CODEN: ZLKHAH 5293
2 . MRI Abstract BACKGROUND: The majority of children with β-thalassemia major have iron overload, and iron overload may have negative effects on hematopoietic stem cell transplantation. OBJECTIVE: To assess the effects of liver and cardiac iron overload detected by magnetic resonance imaging (MRI) T2* on HLA-identical allogeneic hematopoietic stem cell transplantation in children with β-thalassemia major. METHODS: Eighty-one children with β-thalassemia major who were over 3 years of age and could cooperate with MRI detection were subjected to liver and heart MRI T2* tests before or after HLA-identical allogeneic hematopoietic stem cell transplantation. According to the test results, we calculated the liver and cardiac iron content, defined as an indicator of liver and heart iron overload. Then, there was a correlation analysis between the liver and cardiac iron content and serum ferritin, time of hematopoietic reconstitution, mortality rate, implantation rate and the morbidity of transplantation related complications, such as graft-versus-host disease, infections, autoimmune hemolysis, pancytopenia, hepatic veno-occlusive disease, septicemia. RESULTS AND CONCLUSION: The liver iron content was positively correlated with the time of hemoglobin implantation (r=0.229, P=0.043), and the cardiac iron content were positively correlated with the mortality rate (r=0.266, P=0.017); the serum ferritin level was negatively correlated with the implantation rate (r= 0.289, P=0.009), and positively correlated with the morbidity of septicemia (r=0.251, P=0.024) and pancytopenia (r=0.276, P=0.013). Therefore, iron overload exerts negative effects on HLA-identical allogeneic hematopoietic stem cell transplantation in β-thalassemia major children, and it is necessary to detect serum ferritin level and assess liver and cardiac iron overload before cell transplantation. Subject headings: beta-thalassemia; Hematopoietic Stem Cell Transplantation; Iron Overload; Magnetic Resonance Imaging; Tissue Engineering Funding: the Science and Technology Research Project of Guangdong Province, No. 2014A ; the President Fund of Nanfang Hospital, No. 2014B012 Cite this article: Yang WJ, Liao JY, Wen JY, Ruan YS, Chen LB, He YL, Li CF, Wu XD. Liver and cardiac iron overload is harmful to HLA-identical hematopoietic stem cell transplantation in thalassemia children: an MRI detection. Zhongguo Zuzhi Gongcheng Yanjiu. 2017;21(33): Introduction () α β δ β 3% β [1] 0.67% [2] β β (β-thalassemia major β-tm) β [3] [3-5] [6-9] β 81β MRI T2* Subjects and methods βmri T2* > 3 (MRI ) β HLA HLA 6/6 (HLA-A -B -DR) (8.4±3.4) β HLA HLA 6/6 > 3 MRI MRI MRI MRI 81 T2* T2* GE Signa EXCITE 3.0T Siemens 1.5T Magnetom Vision Plus (CMR tools Cardiovascular Imaging Solutions London UK) MRI T2* P.O. Box 10002, Shenyang
3 . MRI BECKMAM COULTER BNPRO NF-08-TM [10] (Cy mg/(kg d) 10 d 9 d)+ (Bu mg/(kg d) 8 d 6 d)+ (Flu 40 mg/(m 2 d) 8 d 4 d)+ (TT 10 mg/(kg d) 5 d)+t ( 5 mg/(kg d) 3 d 1 d) 8 d ( 8 d 7 d)+ ( 6 d 4 d)+( 6 d 2 d)+ ( 3 d) ( ) 5 (MNC) /kg /kg 10% A(CsA)+(MMF) A2 d 1.5 mg/(kg d) 1 d 3 mg/(kg d) A (200±50) ng/l +1 d30 mg/(kg d) +30 d 8 d (heparin) (APTT) s +20 d 12 mg/(kg d) ml/(m 2 d) > ml/(m 2 h) (4 36 ) d > L -1 1 > 70 g/l 1 > L [11-12] > 95% Glucksberg Przepiorka Baltimore < L -1 < < L -1[13-14] [15] 1.6 SPSS13.0 x _ ±s Pearson P < Results (4 36 ) β > 3 MRI 1 Figure 1 Flow chart of the trial HLA MRI 2.3 MRI T2* 81 MRI T2* ms (3.38±3.66) ms mg/g (11.69±6.14) mg/g MRI T2* ms (37.62±13.25) ms mg/g (0.70±0.55) mg/g µg/l ( ± ) µg/l 1 ISSN CN /R CODEN: ZLKHAH 5295
4 . MRI 1 MRI T2* Table 1 Liver and heart MRI T2* results, serum ferritin level and liver and cardiac iron content MRI T2*(ms) (mg/g) MRI T2*(ms) (mg/g) (µg/l) MRI T2* Table 3 Correlation analysis of serum ferritin level with liver and heart MRI T2*, liver and cardiac iron content r P T2* T2* [16] 2.7 ms T2*<6.7 ms 1.4 ms T2* < 2.7 ms T2* <1.4 ms 15 ms T2* < 20 ms 10 ms T2* < 15 ms T2*<10 ms 81 2 >1 000 µg/l [17] 81 β 3 4% 78 96% d18.5 d (19.5±4.83) d 1 60 d14 d (15.45±9.69) d d 14 d (22.32±23.01) d % % % 5 6% 4 5%2 2% 1 1% 2 2% 6 7% % 11 14% 5 6% 1 1% Table 2 Iron overload degree of the liver and heart 7 9% 70 86% 22 27% 7 9% 45 55% 3 4% 7 9% 1 1% 4 Pearson Table 4 Pearson correlation analysis of liver iron content, cardiac iron content, serum ferritin level, and transplantation related complications r P r P r P MRI T2* Pearson T2* (r= P=0.006)(r=0.228 P=0.04) T2* Pearson (r=0.229 P=0.043) (P > 0.05) (r=0.266 P=0.017) (P > 0.05) (r= P=0.009) (r=0.251 P=0.024) (r=0.276 P=0.013) 4 3 Discussion β β [18] P.O. Box 10002, Shenyang
5 . MRI [6-9] C Kolnagou [19] T2*(T2* ) (P < 0.05) T2* 70% 90% [20-21] MRI T2* MRI T2* [22-26] FDA MRI T2* [27] MRI β MRI 81 β 3 < µg/l 78 96% 91% 14% MRI MRI (P < 0.05) [28] [6-7 29] µg/l 2 [8] [30-33] [34] [35] [36] [37] [38-40] [28] % [18] Modell [41] 1980 β Patton [42] β T2* < 10 ms β β ISSN CN /R CODEN: ZLKHAH 5297
6 . MRI (CONSORT ) (STROBE ) 5298 CNKI 3 () References [1] Behrman RE, Kliegman RM, Jenson HB. [M].17. :,2007. [2],,.[M]. :,2015: [3] Cohen AR, Galanello R, Pennell DJ, et al. Thalassemia. Hematology Am Soc Hematol Educ Program. 2004: [4] Beutler E, Hoffbrand AV, Cook JD. Iron deficiency and overload. Hematology Am Soc Hematol Educ Program. 2003: [5]. [J].,2011,16(6): ,255. [6],. [J].,2014,37(6): [7],,. [J].,2016,25(11): [8] Pullarkat V, Blanchard S, Tegtmeier B, et al. Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2008;42(12): [9] Armand P, Kim HT, Cutler CS, et al. Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood. 2007;109(10): [10] Li C, Wu X, Feng X, et al. A novel conditioning regimen improves outcomes in β-thalassemia major patients using unrelated donor peripheral blood stem cell transplantation. Blood. 2012;120(19): [11],. HLA [J].,2005,20(11): [12] Sykes M. Mixed chimerism and transplant tolerance. Immunity. 2001;14(4): [13],. [M]. :,2006: [14],,,.[J].,2001,22(2): [15],. [M].8. :,2013:567. [16] Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2001;22(23): [17] Morrison ED, Brandhagen DJ, Phatak PD, et al. Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis. Ann Intern Med. 2003;138(8): [18],,,. 13 [J].,2014,52(2): [19] Kolnagou A, Natsiopoulos K, Kleanthous M, et al. Liver iron and serum ferritin levels are misleading for estimating cardiac, pancreatic, splenic and total body iron load in thalassemia patients: factors influencing the heterogenic distribution of excess storage iron in organs as identified by MRI T2*. Toxicol Mech Methods. 2013;23(1): [20] Emond MJ, Bronner MP, Carlson TH, et al. Quantitative study of the variability of hepatic iron concentrations. Clin Chem. 1999;45(3): [21] Kataoka K, Nannya Y, Hangaishi A, et al. Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2009;15(2): [22],,,. (T2*) [J]., 2013,33(2): [23] Kirk P, Roughton M, Porter JB, et al. Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation. 2009;120(20): [24],,,. - MRI [J].,2012,46(11): [25] Leung AW, Chu WC, Lam WW, et al. Magnetic resonance imaging assessment of cardiac and liver iron load in transfusion dependent patients. Pediatr Blood Cancer. 2009;53(6): [26] Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2001;22(23): [27] Altes A, Remacha AF, Sarda P, et al. Frequent severe liver iron overload after stem cell transplantation and its possible association with invasive aspergillosis. Bone Marrow Transplant. 2004;34(6): [28],. [J].,2013,52(5): [29] Tachibana T, Tanaka M, Takasaki H, et al. Pretransplant serum ferritin is associated with bloodstream infections within 100 days of allogeneic stem cell transplantation for myeloid malignancies. Int J Hematol. 2011;93(3): [30] Weinberg ED. Iron availability and infection. Biochim Biophys Acta. 2009;1790(7): [31] Bullen JJ, Rogers HJ, Spalding PB, et al. Natural resistance, iron and infection: a challenge for clinical medicine. J Med Microbiol. 2006; 55(Pt 3): [32] Schaible UE, Kaufmann SH. Iron and microbial infection. Nat Rev Microbiol. 2004;2(12): [33] Khan FA, Fisher MA, Khakoo RA. Association of hemochromatosis with infectious diseases: expanding spectrum. Int J Infect Dis. 2007;11(6): [34] Majhail NS, Lazarus HM, Burns LJ. Iron overload in hematopoietic cell transplantation. Bone Marrow Transplant. 2008;41(12): [35] Sahlstedt L, von Bonsdorff L, Ebeling F, et al. Non-transferrin-bound iron in haematological patients during chemotherapy and conditioning for autologous stem cell transplantation. Eur J Haematol. 2009;83(5): [36] Evens AM, Mehta J, Gordon LI. Rust and corrosion in hematopoietic stem cell transplantation: the problem of iron and oxidative stress. Bone Marrow Transplant. 2004;34(7): [37] von Bonsdorff L, Sahlstedt L, Ebeling F, et al. Apotransferrin administration prevents growth of Staphylococcus epidermidis in serum of stem cell transplant patients by binding of free iron. FEMS Immunol Med Microbiol. 2004;40(2): [38] Caroline L, Taschdjian CL, Kozinn PJ, et al. Reversal of serum fungistasis by addition of iron. J Invest Dermatol. 1964;42: [39] Esterly NB, Brammer SR, Crounse RG. The relationship of transferrin and iron to serum inhibition of Candida albicans. J Invest Dermatol. 1967;49(5): [40] Artis WM, Patrusky E, Rastinejad F, et al. Fungistatic mechanism of human transferrin for Rhizopus oryzae and Trichophyton mentagrophytes: alternative to simple iron deprivation. Infect Immun. 1983;41(3): [41] Modell B, Khan M, Darlison M, et al. Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2008;10:42. [42] Patton N, Brown G, Leung M, et al. Observational study of iron overload as assessed by magnetic resonance imaging in an adult population of transfusion-dependent patients with beta thalassaemia: significant association between low cardiac T2* < 10 ms and cardiac events. Intern Med J. 2010;40(6): P.O. Box 10002, Shenyang
High Ferritin Before Transplant Increases Cytopenia Post-transplant in HLA Mismatched Hematopoietic Stem Cell Transplantation in β-thalassemia Major
American Journal of Pediatrics 2018; 4(2): 31-35 http://www.sciencepublishinggroup.com/j/ajp doi: 10.11648/j.ajp.20180402.13 ISSN: 2472-0887 (Print); ISSN: 2472-0909 (Online) High Ferritin Before Transplant
More informationElevated Ferritin Is Associated with Relapse after Autologous Hematopoietic Stem Cell Transplantation for Lymphoma
Elevated Ferritin Is Associated with Relapse after Autologous Hematopoietic Stem Cell Transplantation for Lymphoma Anuj Mahindra, 1 Brian Bolwell, 1 Ronald Sobecks, 1 Lisa Rybicki, 2 Brad Pohlman, 1 Robert
More informationThree-dimensional imaging guided vertebral pedicle screw placement: accuracy analysis doi: /j.issn
19 31 2015 07 23 Chinese Journal of Tissue Engineering Research July 23, 2015 Vol.19, No.31 ( 462000) 1 X 2 118 X X 1971 :R318 :A :2095-4344 (2015)31-04955-05 2015-06-02 http://www.crter.org 2010 12 2013
More informationSurvival and Disease Complication of Thalassemia Major: Experience of 14 Years at King Abdulaziz University Hospital, Jeddah, KSA
JKAU: Med. Sci., Vol. 17 No. 1, pp: 19-28 (2010 A.D. / 1431 A.H.) DOI: 10.4197/Med. 17-1.3 Survival and Disease Complication of Thalassemia Major: Experience of 14 Years at King Abdulaziz University Hospital,
More informationPreventive effect of zoledronic acid on bone loss around the prosthesis stem after hip replacement. doi: /j.issn
19 35 2015 08 27 Chinese Journal of Tissue Engineering Research August 27, 2015 Vol.19, No.35 1 2 1 1 1 ( 1 252400 2 252000) 1 + 2 1 1 2011 2 2014 9 80 40 4 1 3 d 1 1 (P < 0.05) 1 (P < 0.05) 3 d (P < 0.05)
More informationOrigin and trend of the upper eyelid artery in the eyelid region of a skull model after blood reperfusion: an anatomical observation
Chinese Journal of Tissue Engineering Research www.crter.org ( 261 261) DOI:1.3969/j.issn.295-4344.143 ORCID: -3-2218-33() 2 (1) (2) 1988 217 () () 261 :R318 :B 217-1-15 2 X Y (AE) X 24.5.51 1/2 23 24.6.55±.5
More informationShort-term effects of anterior cruciate ligament reconsruction with femoral tunnel suspension fixation on bone tunnel and graft change
20 35 20160826 Chinese Journal of Tissue Engineering Research August 26, 2016 Vol.20, No.35 ( 550001). [J]. 201620(35): 5284-5289. DOI: 10.3969/j.issn.2095-4344.2016.35.017 ORCID: 0000-0003-3063-6918()
More informationKeisuke Kataoka, 1 Yasuhito Nannya, 1 Akira Hangaishi, 1 Yoichi Imai, 1 Shigeru Chiba, 2 Tsuyoshi Takahashi, 1 Mineo Kurokawa 1,2
Influence of Pretransplantation Serum Ferritin on Nonrelapse Mortality after Myeloablative and Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation Keisuke Kataoka, 1 Yasuhito Nannya, 1
More informationEstablishment of an individualized three-dimensional finite element model of type A coronary artery lesions (36):
21 36 2017 12 28 Chinese Journal of Tissue Engineering Research December 28, 2017 Vol.21, No.36 A 3D ( 010059). A 3D [J]. 2017 21(36):5841-5846. DOI:10.3969/j.issn.2095-4344.2017.36.018 ORCID: 0000-0003-1168-0534(
More informationCalcium alginate/bone marrow mesenchymal stem cells combined with degradation membrane for repair of skin defects
19 32 2015 08 06 Chinese Journal of Tissue Engineering Research August 6, 2015 Vol.19, No.32 1 2 2 3 4 2 5 ( 1 116044 2 5 110034 3 110024 4 110000) 1 2 3 C 2 15 3 ( ) ( 1 ) ( 2 ) 7 14 21 d 14 21 d 21 d
More informationTransforming growth factor beta1 gene silenced adipose-derived stem cell transplantation reduces thrombocytopenic purpura
21 1 2017 01 08 Chinese Journal of Tissue Engineering Research January 8, 2017 Vol.21, No.1 β1 ( 050031). β1 [J]. 2017 21(1):60-65. DOI: 10.3969/j.issn.2095-4344.2017.01.011 ORCID:0000-0002-3236-5704()
More informationFinite element analysis of skin closure stress in different directions
21 4 2017 02 08 Chinese Journal of Tissue Engineering Research February 8, 2017 Vol.21, No.4 1 1 2 ( 1 030024 2 030009). [J]. 2017 21(4):609-614. DOI:10.3969/j.issn.2095-4344.2017.04.020 ORCID: 0000-0002-2818-4361()
More information0 Introduction (20.9%) [7]
Chinese Journal of Tissue Engineering Research www.crter.org ( 443000) DOI:10.3969/j.issn.2095-4344.0187 ORCID: 0000-0003-0005-1839() 60 120 2 60 1980 2015 443000 :R318 :A 2017-12-05 3 4 120 60 () 3 (P
More informationApplication of three-dimensional reconstruction using Mimics software to repair of Pilon fracture. doi: /j.issn
19 44 20151022 Chinese Journal of Tissue Engineering Research October 22, 2015 Vol.19, No.44 MimicsPilon ( 528415) 1 Pilon 2 CT Mimics V 10.0 Pilon 3 Pilon Mimics Mimics Mimics Pilon (20113A014) Mimics
More informationEvaluation of Cardiac Iron Load by Cardiac Magnetic Resonance in Thalassemia
R E S E A R C H P A P E R Evaluation of Cardiac Iron Load by Cardiac Magnetic Resonance in Thalassemia RASHID MERCHANT, ADITI JOSHI, JAVED AHMED, *PRADEEP KRISHNAN AND *BHAVIN JANKHARIA From the Department
More informationPedicle screw placement combined with filler for lumbar vertebra fractures 19(22): doi: /j.issn
19 22 2015 05 28 Chinese Journal of Tissue Engineering Research May 28, 2015 Vol.19, No.22 1 2 1 1 ( 1 830002 2 830002) 1 2 3 (XYDCX2014185) / Cobb 1981 2005 830002 :R318 :B :2095-4344 (2015)22-03590-05
More informationKEY WORDS: Allogeneic stem cell transplant, Iron overload, SQUID
Iron Overload in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation: Quantification of Iron Burden by a Superconducting Quantum Interference Device (SQUID) and Therapeutic Effectiveness
More informationSafety of epidural combined with small-dose intravenous anesthesia during total knee arthroplasty in elderly patients with hypertension
19 35 2015 08 27 Chinese Journal of Tissue Engineering Research August 27, 2015 Vol.19, No.35 1 2 3 3 4 5 ( 1 3 4 5 054300 2 050051) 1 2 3 2013 12 2014 12 64 32 10 min 10 min ( ) 10 min 10 min (P < 0.05)
More informationDOI: /j.issn ORCID: ( )
20 34 2016 08 19 Chinese Journal of Tissue Engineering Research August 19, 2016 Vol.20, No.34 ( 810001). [J]. 2016 20(34):5163-5168. DOI: 10.3969/j.issn.2095-4344.2016.34.023 ORCID: 0000-0003-1929-7900(
More informationFerriScan provides an accurate assessment of body iron stores
FerriScan provides an accurate assessment of body iron stores A clinician s guide to managing transfusional iron overload with FerriScan Transfusional iron overload Patients receiving multiple blood transfusions
More informationArticle Stem cell transplantation for thalassaemia
RBMOnline - Vol 10. No 1. 2005 111-115 Reproductive BioMedicine Online; www.rbmonline.com/article/1525 on web 10 November 2004 Article Stem cell transplantation for thalassaemia Dr Javid Gaziev Javid Gaziev
More informationChinese Journal of Tissue Engineering Research December 28, 2017 Vol.21, No.36 ISSN CN /R CODEN: ZLKHAH 5763
21 36 20171228 Chinese Journal of Tissue Engineering Research December 28, 2017 Vol.21, No.36 1 ( 830063). [J]. 201721(36):5763-5768. DOI:10.3969/j.issn.2095-4344.2017.36.005 ORCID: 0000-0003-2732-055X()
More information(14): DOI: /j.issn ORCID: ( )
20 14 2016 04 01 Chinese Journal of Tissue Engineering Research April 1, 2016 Vol.20, No.14 ( 473000). [J]. 2016 20(14):2033-2039. DOI: 10.3969/j.issn.2095-4344.2016.14.008 ORCID: 0000-0002-8672-7109()
More informationRelationship between low basal metabolic rate and mortality in older adults with hip fractures
Chinese Journal of Tissue Engineering Research www.crter.org ( 221006) DOI:10.3969/j.issn.2095-4344.0218 ORCID: 0000-0002-8618-0967() 1 30 d ( 2 h ) 1992 221006 :R318 :A 2018-01-13 1 2014 1 2016 3 507
More informationLONG TERM FOLLOW-UP OF PATIENTS WITH FANCONI ANEMIA AFTER ALLOGENEIC T-CELL DEPLETED HEMATOPOITEIC STEM CELL TRANSPLANTATION FROM ALTERNATIVE DONORS
LONG TERM FOLLOW-UP OF PATIENTS WITH FANCONI ANEMIA AFTER ALLOGENEIC T-CELL DEPLETED HEMATOPOITEIC STEM CELL TRANSPLANTATION FROM ALTERNATIVE DONORS Farid Boulad, Susan E Prockop, Praveen Anur, Danielle
More informationReduced-intensity Conditioning Transplantation
Reduced-intensity Conditioning Transplantation Current Role and Future Prospect He Huang M.D., Ph.D. Bone Marrow Transplantation Center The First Affiliated Hospital Zhejiang University School of Medicine,
More informationHematopoietic Stem Cell Transplant in Sickle Cell Disease- An update
Hematopoietic Stem Cell Transplant in Sickle Cell Disease- An update Dr Chirag A Shah Diplomate American Board of Hematology and Medical Oncology Director, Dept of Hemato-Oncology and Stem Cell Transplant
More informationA.M.W. van Marion. H.M. Lokhorst. N.W.C.J. van de Donk. J.G. van den Tweel. Histopathology 2002, 41 (suppl 2):77-92 (modified)
chapter 4 The significance of monoclonal plasma cells in the bone marrow biopsies of patients with multiple myeloma following allogeneic or autologous stem cell transplantation A.M.W. van Marion H.M. Lokhorst
More informationMcAb and rhil-2 activated bone marrow on the killing and purging of leukemia cells
Effects of McAb and rhil-2 activated bone marrow on the killing and purging of leukemia cells X.C. Wei, D.D. Yang, X.R. Han, Y.A. Zhao, Y.C. Li, L.J. Zhang and J.J. Wang Institute of hematological research,
More informationhematopoietic cell transplantation. Citation Bone marrow transplantation (2011),
Pretransplant serum ferritin and C- Titlefactors for early bacterial infecti hematopoietic cell transplantation. Kanda, J; Mizumoto, C; Ichinohe, T; Author(s) Yamashita, K; Kondo, T; Takakura, S T; Ishikawa,
More informationBone Marrow Transplantation and the Potential Role of Iomab-B
Bone Marrow Transplantation and the Potential Role of Iomab-B Hillard M. Lazarus, MD, FACP Professor of Medicine, Director of Novel Cell Therapy Case Western Reserve University 1 Hematopoietic Cell Transplantation
More informationAre We There Yet? Gene Therapy and BMT as Curative Therapies in Sickle Cell. Ann Haight, MD 9 Sept 2017
Are We There Yet? Gene Therapy and BMT as Curative Therapies in Sickle Cell Ann Haight, MD 9 Sept 2017 Spoiler alert Yes (we have a cure) And No Work to do! 2 Sickle Cell Treatment Options Supportive Care
More informationIntroduction to Clinical Hematopoietic Cell Transplantation (HCT) George Chen, MD Thursday, May 03, 2018
Introduction to Clinical Hematopoietic Cell Transplantation (HCT) George Chen, MD Thursday, May 03, 2018 The transfer of hematopoietic progenitor and stem cells for therapeutic purposes Hematopoietic Cell
More information0 Introduction. (1.8±0.8) mm (3.9±0.6) mm Muller. (2.12±0.58) mm (2.89±0.64) mm Song [10] Giano) (110 kvp 15 ma 36 s voxel size
21 24 20170828 Chinese Journal of Tissue Engineering Research August 28, 2017 Vol.21, No.24 CBCT ( () 510280 510515 310000). CBCT [J]. 201721(24):3803-3808. DOI:10.3969/j.issn.2095-4344.2017.24.006 ORCID:
More informationNeed considerable resources material and human.
TRAN VAN BINH INTRODUCTION Hematopoietic Stem cell transplantation: the best way to manage Malignancies and non Malignant blood disorders. Need considerable resources material and human. In developping
More informationTHE ROLE OF TBI IN STEM CELL TRANSPLANTATION. Dr. Biju George Professor Department of Haematology CMC Vellore
THE ROLE OF TBI IN STEM CELL TRANSPLANTATION Dr. Biju George Professor Department of Haematology CMC Vellore Introduction Radiotherapy is the medical use of ionising radiation. TBI or Total Body Irradiation
More informationDonor Lymphocyte Infusion for Malignancies Treated with an Allogeneic Hematopoietic Stem-Cell Transplant
Last Review Status/Date: September 2014 Page: 1 of 8 Malignancies Treated with an Allogeneic Description Donor lymphocyte infusion (DLI), also called donor leukocyte or buffy-coat infusion is a type of
More informationDr.PSRK.Sastry MD, ECMO
Peripheral blood stem cell transplantation (Haematopoietic stem cell transplantation) Dr.PSRK.Sastry MD, ECMO Consultant, Medical Oncology Kokilaben Dhirubhai Ambani Hospital Normal hematopoiesis Historical
More informationHaemoglobinophaties EBMT 2011 Data Manager session
Haemoglobinophaties EBMT 2011 Data Manager session Presentation plan Biological characteristics Clinical characteristics Transplant resuts What is different From transplant in malignancies Between Thalassemia
More informationMyeloablative and Reduced Intensity Conditioning for HSCT Annalisa Ruggeri, MD, Hôpital Saint Antoine Eurocord- Hôpital Saint Louis, Paris
Myeloablative and Reduced Intensity Conditioning for HSCT Annalisa Ruggeri, MD, Hôpital Saint Antoine Eurocord- Hôpital Saint Louis, Paris 18th ESH - EBMT Training Course on HSCT 8-10 May 2014, Vienna,
More informationIron Overload in Patients with Acute Leukemia or MDS Undergoing Myeloablative Stem Cell Transplantation
Iron Overload in Patients with Acute Leukemia or MDS Undergoing Myeloablative Stem Cell Transplantation Philippe Armand, 1 Haesook T. Kim, 2 Joanna Rhodes, 3 Marie-Michele Sainvil, 1 Corey Cutler, 1 Vincent
More informationPeking University People's Hospital, Peking University Institute of Hematology
Qian Jiang, M.D. Peking University People's Hospital, Peking University Institute of Hematology No. 11 Xizhimen South Street, Beijing, 100044, China. Phone number: 86-10-66583802 Mobile: 86-13611115100
More informationTransfusions in Sickle Cell Disease: How, When and Why
Transfusions in Sickle Cell Disease: How, When and Why James R. Eckman, MD Professor Emeritus of Hematology and Medical Oncology Emory University School of Medicine This work is supported by the Centers
More informationDisclosers Updates: Management of Aplastic Anemia and Congenital Marrow Failure 5/9/2017
2017 Updates: Management of Aplastic Anemia and Congenital Marrow Failure Sachit Patel, MD Department of Pediatrics Division of Hematology-Oncology Blood and Marrow Transplantation Disclosers None 1 Objectives:
More information5/9/2018. Bone marrow failure diseases (aplastic anemia) can be cured by providing a source of new marrow
5/9/2018 or Stem Cell Harvest Where we are now, and What s Coming AA MDS International Foundation Indianapolis IN Luke Akard MD May 19, 2018 Infusion Transplant Conditioning Treatment 2-7 days STEM CELL
More informationCell block technology in the pathological diagnosis of pleural effusion
Chinese Journal of Tissue Engineering Research ( 100034) DOI:10.3969/j.issn.2095-4344.0210 ORCID: 0000-0002-3811-5490() www.crter.org (1) 105 (2) 1989 2009 100034 :R318 :B 2018-03-07 2016 1 2017 8 105
More informationIron overload in MDS
Iron overload in MDS Theo de Witte Radboud University Medical Centre Nijmegen, Netherlands MDS Subcommittee of the Chronic Leukemia Working Party of the EBMT Anja van Biezen, Marijke Scholten, Ronald Brand,
More informationFederica Galaverna, 1 Daria Pagliara, 1 Deepa Manwani, 2 Rajni Agarwal-Hashmi, 3 Melissa Aldinger, 4 Franco Locatelli 1
Administration of Rivogenlecleucel (Rivo-cel, BPX-501) Following αβ T- and B-Cell Depleted Haplo-HSCT in Children With Transfusion-Dependent Thalassemia Federica Galaverna, 1 Daria Pagliara, 1 Deepa Manwani,
More informationIndex. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Acute lymphoblastic leukemia, in India, 439 440 pediatric, global approach to, 420 424 core resources in low- and middle-income countries, 423
More informationBlood and Marrow Transplantation for Haemoglobinopathies. Dr Josu de la Fuente St. Mary s Hospital London
Blood and Marrow Transplantation for Haemoglobinopathies Dr Josu de la Fuente St. Mary s Hospital London Aim: Stem Cell Transplanta.on 1. Eradicate of disease = achieve myeloabla8on 2. Avoid rejec8on
More informationΧριστίνα Χρυσοχόου Α Καρδιολογική Κλινική Πανεπιστηίου Αθηνών
Ιωάννης Ανδρέου Χριστίνα Χρυσοχόου Α Καρδιολογική Κλινική Πανεπιστηίου Αθηνών Ιπποκράτειο Γ.Ν.Α Splenectomy at the age of 7yrs Episodes of persistent atrial fibrillation Hypothyroidism Osteoporosis Noncompliant
More informationPost Transplant Management for Sickle Cell. Title
Post Transplant Management for Sickle Cell Title Kimberly Kasow, DO October 14, 2016 Thank you for this opportunity to present this information I have no financial interests to disclose. Goal of Transplant
More informationDonatore HLA identico di anni o MUD giovane?
Donatore HLA identico di 60-70 anni o MUD giovane? Stella Santarone Dipartimento di Ematologia, Medicina Trasfusionale e Biotecnologie Pescara AGENDA 1. Stem Cell Donation: fatalities and severe events
More informationCorporate Medical Policy
Corporate Medical Policy Hematopoietic Stem-Cell Transplantation for Waldenstrom Macroglobulinemia File Name: Origination: Last CAP Review: Next CAP Review: Last Review: hematopoietic_stem_cell_transplantation_for_waldenstrom_macroglobulinemia
More informationEMERGING FUNGAL INFECTIONS IN IMMUNOCOMPROMISED PATIENTS
EMERGING FUNGAL INFECTIONS IN IMMUNOCOMPROMISED PATIENTS DR LOW CHIAN YONG MBBS, MRCP(UK), MMed(Int Med), FAMS Consultant, Dept of Infectious Diseases, SGH Introduction The incidence of invasive fungal
More information2/4/14. Disclosure. Learning Objective
Utilizing Intravenous Busulfan Pharmacokinetics for Dosing Busulfan And Fludarabine Conditioning Regimens In Institutions Where The Capability Of Doing Pharmacokinetics Is Not Present Shaily Arora, PharmD
More informationEXPERIMENTAL AND THERAPEUTIC MEDICINE 9: , 2015
EXPERIMENTAL AND THERAPEUTIC MEDICINE 9: 1895-1900, 2015 Clinical characteristics of a group of patients with multiple myeloma who had two different λ light chains by immunofixation electrophoresis: A
More informationHow Early Can Myocardial Iron Overload Occur in Beta Thalassemia Major?
How Early Can Myocardial Iron Overload Occur in Beta Thalassemia Major? Gaohui Yang 1., Rongrong Liu 1., Peng Peng 2, Liling Long 2, Xinhua Zhang 3, Weijia Yang 4, Shaohong Tan 5, Hongfei Pan 6, Xingjiang
More informationClinical Guidelines on the Use of Iron Chelation in Children Receiving Regular Blood Transfusions
Clinical Guidelines on the Use of Iron Chelation in Children Receiving Regular Blood Transfusions Version: 1 Date: 4 th May 2010 Authors: Responsible committee or Director: Review date: Target audience:
More informationOutcomes of Transplantation with Related- and Unrelated-Donor Stem Cells in Children with Severe Thalassemia
Biology of Blood and Marrow Transplantation 12:683-687 (2006) 2006 American Society for Blood and Marrow Transplantation 1083-8791/06/1206-0011$32.00/0 doi:10.1016/j.bbmt.2006.02.008 Outcomes of Transplantation
More informationBusulfan/Cyclophosphamide (BuCy) versus Busulfan/Fludarabine (BuFlu) Conditioning Regimen Debate
Busulfan/Cyclophosphamide (BuCy) versus Busulfan/Fludarabine (BuFlu) Conditioning Regimen Debate Donald Hutcherson, RPh Clinical Pharmacy Specialist BMT Emory University Hospital/Winship Cancer Institute
More informationLondon, 27 October 2005 Product Name: Busilvex Procedure no.: EMEA/H/C/472/II/0004 SCIENTIFIC DISCUSSION
London, 27 October 2005 Product Name: Busilvex Procedure no.: EMEA/H/C/472/II/0004 SCIENTIFIC DISCUSSION 1 Introduction Busilvex contains the active substance busulfan in a concentrate for solution for
More informationFAQ on FerriScan asked by clinical communities
FAQ on FerriScan asked by clinical communities We measure cardiac T2* of our patients, why is it important to measure liver iron concentration (LIC) as well? Measuring cardiac T2* is important as a significant
More informationHCT for Myelofibrosis
Allogeneic HSCT for MDS and Myelofibrosis Sunil Abhyankar, MD Professor Medicine, Medical Director, Pheresis and Cell Processing University of Kansas Hospital BMT Program April 27 th, 213 HCT for Myelofibrosis
More informationMyelodysplastic syndrome. Jeanne Palmer, MD Mayo Clinic, Arizona
Myelodysplastic syndrome Jeanne Palmer, MD Mayo Clinic, Arizona What is Myelodysplastic syndrome? A disease where the bone marrow doesn t work appropriately What does that mean?? Red blood cells Carry
More informationTreating Higher-Risk MDS. Case presentation. Defining higher risk MDS. IPSS WHO IPSS: WPSS MD Anderson PSS
Treating Higher-Risk MDS Eyal Attar, M.D. Massachusetts General Hospital Cancer Center eattar@partners.org 617-724-1124 Case presentation 72 year old man, prior acoustic neuroma WBC (X10 3 /ul) 11/08 12/08
More informationSickle Cell Diseasechronic. curable disease? Objectives. Why would a family ask about cure for SCD?
Sickle Cell Diseasechronic illness or curable disease? Gregory M.T. Guilcher MD, FRCPC, FAAP Objectives To review the general principles of hematopoietic stem cell transplantation (HSCT), including risks
More informationAn Approach to the Patient Refractory to Platelets Transfusion. Harold Alvarez, MD
Harold Alvarez, MD Objectives Explain the etiology of platelet refractoriness Discuss the different types of platelet refractoriness Describe how platelet refractoriness is diagnosed Discuss different
More informationSpinal motor neurons from neonatal rats: purification, culture and identification doi: /j.issn
19 42 2015 10 08 Chinese Journal of Tissue Engineering Research October 8, 2015 Vol.19, No.42 (/ 116024), (2013023035)(2013E15SF171) Hoechst 85.8% 71.6% 7.8% NF200 6.4% 1987 116024 :R318 :B :2095-4344
More informationExperience of patients transplanted with naïve T cell depleted stem cell graft in CMUH
Experience of patients transplanted with naïve T cell depleted stem cell graft in CMUH Tzu-Ting Chen, Wen-Jyi Lo, Chiao-Lin Lin, Ching-Chan Lin, Li-Yuan Bai, Supeng Yeh, Chang-Fang Chiu Hematology and
More informationCase-Control Study: ABO-Incompatible Plasma Causing Hepatic Veno-Occlusive Disease in HSCT
Case-Control Study: ABO-Incompatible Plasma Causing Hepatic Veno-Occlusive Disease in HSCT Erin Meyer, DO, MPH Assistant Medical Director of Blood, Tissue, and Apheresis Services Children s Healthcare
More information(2016JY03) Huang Xue-cheng, Ye Lin-qiang, Liang De, Wang Qian-li, Yu Wei-bo, Jiang Xiao-bing
Chinese Journal of Tissue Engineering Research www.crter.org ( 510405 510405) DOI:10.3969/j.issn.2095-4344.0038 ORCID: 0000-0002-8009-0282() 1988 510405 () () :R318 A 2017-11-15 1 25 CT Mimics10.01Geomagic
More informationVascular grafts made of expanded polytetrafluoroethylene for repair of peripheral arterial injuries 19(34):
19 34 2015 08 20 Chinese Journal of Tissue Engineering Research August 20, 2015 Vol.19, No.34 ( 430000) 38 30 8 17 61 12 100% 12 92%(35/38) 1974 430000 :R318 :B :2095-4344 (2015)34-05496-05 2015-06-09
More informationHematopoietic Stem Cell Transplantation for Patients with Chronic Myeloid Leukemia
398 Hematopoietic Stem Cell Transplantation for Patients with Chronic Myeloid Leukemia Qifa Uu Zhiping Fan Jing Sun Yu Zhang Xiaoli Uu Dan Xu Bing Xu Ru Feng Fanyi Meng Shuyun Zhou Department of Hematology,
More informationWhat s a Transplant? What s not?
What s a Transplant? What s not? How to report the difference? Daniel Weisdorf MD University of Minnesota Anti-cancer effects of BMT or PBSCT [HSCT] Kill the cancer Save the patient Restore immunocompetence
More informationAllogeneic Hematopoietic Stem-Cell Transplantation for Myelodysplastic Syndromes and Myeloproliferative Neoplasms. Policy Specific Section:
Medical Policy Allogeneic Hematopoietic Stem-Cell Transplantation for Myelodysplastic Syndromes and Myeloproliferative Type: Medical Necessity and Investigational / Experimental Policy Specific Section:
More informationClinical Policy: Allogenic Hematopoietic Cell Transplants for Sickle Cell Anemia and β-thalassemia
Clinical Policy: Allogenic Hematopoietic Cell Transplants for Sickle Cell Anemia and β-thalassemia Reference Number: CP.MP.108 Effective Date: 03/16 Last Review Date: 03/17 See Important Reminder at the
More informationEffects of changes in serum endostatin and fibroblast growth factor 19 on the chemotherapeutic sensitivity in acute myeloid leukemia patients
Effects of changes in serum endostatin and fibroblast growth factor 19 on the chemotherapeutic sensitivity in acute myeloid leukemia patients Y.Z. Su 1, C.B. Wang 2, Y. Zhou 2 and N.T. Sun 2 1 Department
More information12 Dynamic Interactions between Hematopoietic Stem and Progenitor Cells and the Bone Marrow: Current Biology of Stem Cell Homing and Mobilization
Table of Contents: PART I: Molecular and Cellular Basis of Hematology 1 Anatomy and Pathophysiology of the Gene 2 Genomic Approaches to Hematology 3 Regulation of Gene Expression, Transcription, Splicing,
More informationMultidisciplinary care. Michael Angastiniotis
Multidisciplinary care Michael Angastiniotis Pathopysiology of β-thalassaemia Thalassaemia syndromes are inherited haemoglobin disorders caused by defective and imbalanced globin production Excess free
More informationLate complications after hematopoietic stem cell transplant in adult patients
Late complications after hematopoietic stem cell transplant in adult patients Gérard Socié, MD, PhD Hematology/Transplantation, Hospital Saint Louis, Paris, France Synopsis H S C T Allogeneic HSCT activity
More informationClinical Study Steroid-Refractory Acute GVHD: Predictors and Outcomes
Advances in Hematology Volume 2011, Article ID 601953, 8 pages doi:10.1155/2011/601953 Clinical Study Steroid-Refractory Acute GVHD: Predictors and Outcomes Jason R. Westin, 1 Rima M. Saliba, 1 Marcos
More informationOne Day BMT Course by Thai Society of Hematology. Management of Graft Failure and Relapsed Diseases
One Day BMT Course by Thai Society of Hematology Management of Graft Failure and Relapsed Diseases Piya Rujkijyanont, MD Division of Hematology-Oncology Department of Pediatrics Phramongkutklao Hospital
More informationThe primary medical content categories of the blueprint are shown below, with the percentage assigned to each for a typical exam:
Hematology Certification Examination Blueprint Purpose of the exam The exam is designed to evaluate the knowledge, diagnostic reasoning, and clinical judgment skills expected of the certified hematologist
More informationWaveflex elastic fixation and discectomy annulus in repair and reconstruction of spinal stability in patients with lumbar disc herniation
19 44 20151022 Chinese Journal of Tissue Engineering Research October 22, 2015 Vol.19, No.44 Waveflex ( 221009) 1 Waveflex 2 3 Waveflex Waveflex (XZB201311) Waveflex Waveflex 38 18 Waveflex 20 (JOA)Oswestry
More informationCheckpoint Blockade in Hematology and Stem Cell Transplantation
Checkpoint Blockade in Hematology and Stem Cell Transplantation Saad S. Kenderian, MD Assistant Professor of Medicine and Oncology Mayo Clinic College of Medicine October 14, 2016 2015 MFMER slide-1 Disclosures
More informationApproach to the Transplant Patient. Amy Musiek, MD AAD Annual Meeting 2018
Approach to the Transplant Patient Amy Musiek, MD AAD Annual Meeting 2018 Disclosures Actelion: speaker, advisory board, investigator Elorac: investigator Kyowa: investigator, advisory board Seattle genetics:
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: (Exjade, Jadenu) Reference Number: CP.PHAR.145 Effective Date: 11.01.15 Last Review Date: 08.18 Line of Business: Commercial, HIM, Medicaid Revision Log See Important Reminder at the end
More informationStem cell transplantation for haemoglobinopathies. Dr P J Darbyshire Birmingham Childrens Hospital
Stem cell transplantation for haemoglobinopathies Dr P J Darbyshire Birmingham Childrens Hospital Survival by Cohort of Birth (N=977) 1.00 85-97 80-84 75-79 70-74 0.75 Survival Probability 0.50 0.25 P
More informationORIGINAL ARTICLE INTRODUCTION THE KOREAN JOURNAL OF HEMATOLOGY
VOLUME 45 ㆍ NUMBER 2 ㆍ June 2010 THE KOREAN JOURNAL OF HEMATOLOGY ORIGINAL ARTICLE Fludarabine-based myeloablative regimen as pretransplant conditioning therapy in adult acute leukemia/myelodysplastic
More informationTransplantation - Challenges for the future. Dr Gordon Cook S t James s Institute of Oncology, Leeds Teaching Hospitals Trust
Transplantation - Challenges for the future Dr Gordon Cook S t James s Institute of Oncology, Leeds Teaching Hospitals Trust Bone Marrow Transplantation Timeline, 1957-2006 Appelbaum F. N Engl J Med 2007;357:1472-1475
More informationSpanish Donor Registry. Follow-Up Data
Spanish Donor Registry. Follow-Up Data Javier de la Rubia S. de Hematología Hospital La Fe Valencia 16th Haemovigilance Seminar Barcelona, March 2014 WHO declared 2010 in its Guiding principle Nr.10: Hig-quality,
More informationExtramedullary Relapse of the AML Transformed from MDS Following Auto-HSCT: A Case Report
Cell Biochem Biophys (2014) 70:409 414 DOI 10.1007/s12013-014-9926-3 ORIGINAL PAPER Extramedullary Relapse of the AML Transformed from MDS Following Auto-HSCT: A Case Report Jin Wang Yu Liu Xu Zhou Zheng
More informationACGME Program Requirements for Graduate Medical Education in Pediatric Hematology-Oncology
ACGME Program Requirements for Graduate Medical Education in Pediatric Hematology-Oncology ACGME approved: June 27, 2006; effective: July 1, 2007 ACGME approved focused revision: September 30, 2012; effective:
More informationNRS2002 assesses nutritional status of leukemia patients undergoing hematopoietic stem cell transplantation
Original Article NRS2002 assesses nutritional status of leukemia patients undergoing hematopoietic stem cell transplantation Peng Liu 1*, Zhao-Feng Zhang 2*, Jing-Jing Cai 1, Bo-Shi Wang 1, Xia Yan 3 1
More informationWorkshop I: Patient Selection Current indication for HCT in adults. Shinichiro Okamoto MD, PhD Keio University, Tokyo, Japan
Workshop I: Patient Selection Current indication for HCT in adults Shinichiro Okamoto MD, PhD Keio University, Tokyo, Japan Factors to Take into Account with Recommending HCT Patient & disease factors
More informationOutline Pretransplant Essential data Why comorbidities are important? For patients with cancer For patients given allogeneic HCT
Comorbidities before Allogeneic Hematopoietic Cell Transplantation (HCT) The HCT-specific Comorbidity Index (HCT-CI) Mohamed Sorror, M.D., M.Sc. FHCRC Seattle, WA Outline Pretransplant Essential data Why
More informationAutografting as a risk factor for persisting iron overload in long-term survivors of acute myeloid leukaemia
(2003) 32, 909 913 & 2003 Nature Publishing Group All rights reserved 0268-3369/03 $25.00 www.nature.com/bmt Autografting as a risk factor for persisting iron overload in long-term survivors of acute myeloid
More informationUNRELATED DONOR TRANSPLANTATION FOR SICKLE CELL DISEASE AN UPDATE
UNRELATED DONOR TRANSPLANTATION FOR SICKLE CELL DISEASE AN UPDATE Naynesh Kamani, M.D. Children s National Medical Center GW University School of Medicine Washington, DC SCD scope of problem in USA Commonest
More information